Influence of Epstein-Barr Virus Encoded Latent Membrane Protein 1 on the Expression of CD23 Antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg Cells. A Morphometric Analysis

References

• Pallesen G. The association of Epstein-Barr virus with Hodgkin's disease. Advances in Tumor Immunology and Allergic Disorders, F. Dammaco. Edi. Ernies, Milan 1992, (in press. In:
   Google Scholar
• Rosdahl N., Larsen S. O., Clemmesen J. Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience. Br. Med. J. 1974; 2: 253–256
   PubMed Web of Science ®Google Scholar
• Munoz N, Davidson R. J. L., Witthof B., Ericsson J. E., De-The G. Infectious mononucleosis and Hodgkin's disease. Int. J. Cancer 1978; 22: 10–13
   PubMed Web of Science ®Google Scholar
• Johansson B., Klein G., Henle W., Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. 1. Hodgkin's disease. Int. J. Cancer 1970; 6: 450–462
   PubMed Web of Science ®Google Scholar
• Evans A. S., Gutensohn N. M. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int. J. Cancer 1984; 34: 149–157
   PubMed Web of Science ®Google Scholar
• Mueller N., Evans A., Harris N. L., Comstock W., Jellum E., Magnus K., Orentreich N., Polk B. F., Vogelman J. Hodgkin's disease and Epstein-Barr virus, altered antibody patterns before diagnosis. N. Engl. J. Med. 1989; 320: 689–695
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Strickler J. G., Warnke R. A., Purtilo D. T., Sklar J. Epstein-Barr viral DNA in tissue of Hodgkin's disease. Am. J. Pathol. 1987; 129: 86–91
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Herbst H., Niedobitek G., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-l-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810–816
   PubMed Web of Science ®Google Scholar
• Herbst H., Niedobitek G., Kneba M., Hummel M., Finn T., Anagnostopoulos I., Bergholz M., Krieger G., Stein H. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol. 1990; 137: 13–18
   PubMed Web of Science ®Google Scholar
• Klein G. Viral latency and transformation: The strategy of Epstein-Ban- virus. Cell 1989; 58: 5–8
   PubMed Web of Science ®Google Scholar
• Wang F., Gregory C. D., Rowe M., Rickinson A. B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 1987; 84: 3452–3456
   PubMed Web of Science ®Google Scholar
• Wang F., Gregory C. D., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear protein 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 1990; 64: 2309–2318
   PubMed Web of Science ®Google Scholar
• Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A. B., Larson R., Springer T., Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J. Virol. 1988; 62: 4173–4184
   PubMed Web of Science ®Google Scholar
• Gregory C. D., Murray R. J., Edwards C. F., Rickinson A. B. Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumour cell escape from virus-specific cytotoxic T cell surveilance. J Exp. Med. 1988; 167: 1811–1824
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Pallesen G. The distribution of CD23 in normal human tissue and in malignant lymphomas. In:. Leucocyte Typing III: White Cell Differentiation Antigens, A. J. McMichael. Oxford University Press, Oxford 1987; 383–386
   Google Scholar
• Rowlands D. C., Hansel T. T., Crocker J. Immunohistological determination of CD23 expression in Hodgkin's disease using paraffin sections. J. Pathol. 1990; 160: 239–243
   PubMed Web of Science ®Google Scholar
• Sanders M. E., Makgoba M. W., Sussman E. H., Luce G. E. G., Cossman J., Shaw S. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428. Cancer Res. 1988; 48: 37–40
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Hsu P. L. Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells. Am. J. Pathol. 1990; 137: 563–574
   PubMed Web of Science ®Google Scholar
• Gundersen H. J. G. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microscopy 1977; 111: 219–223
   Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Müller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed– Sternberg cells. Proc. Natl. Acad. Sci. USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Brousset P., Chittal S., Delsol G. Epstein-Barr virus gene expression in Hodgkin's disease. Blood 1991; 78: 1629–1630
   Web of Science ®Google Scholar
• Thorley-Lawson D. A., Nadler L. M., Bhan A. K., Schooley R. T. BLAST-2 (EBVCS), an early cell surface marker of human B cell activation, is superinduced by Epstein-Barr virus. J. Immunol. 1985; 134: 3007–3012
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D. A., Mann K. P. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 1985; 162: 45–59
   PubMed Web of Science ®Google Scholar
• Calender A., Billaud M., Aubry J. P., Banchereau J., Vuillame M., Lenoir G. M. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 1987; 84: 8060–8064
   PubMed Web of Science ®Google Scholar
• Jarrett R. F., Armstrong A., Wilkins B. S., Jones D. B. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections. J. Pathol. 1991; 160: 345–346
   Web of Science ®Google Scholar
• Young L., Alfieri C., Hennessy K., Evans H., O'Hara C., Anderson K. C., Ritz J., Shapiro R. S., Rickinson A., Kieff E., Cohen J. I. Expression of Epstein Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 1989; 321: 1080–85
   PubMed Web of Science ®Google Scholar
• Thomas J. A., Hotchin N. A., Allday M. J., Amlot P., Rose M., Yacoub M., Crawford D. H. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplant. 1990; 49: 944–953
   PubMed Web of Science ®Google Scholar
• Delespesse G., Sarfati M., Peleman R. Influence of recombinant IL-4, IFN-α, and IFN-Γ on the production of human igE-binding factor (soluble CD23). J. Immunol. 1989; 142: 134–138
   PubMed Web of Science ®Google Scholar
• Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831–840
   PubMed Web of Science ®Google Scholar
• Murray R. J., Wang D., Young L. S., Wang F., Rowe M., Kieff E., Rickinson A. B. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol. 1988; 62: 3747–3755
   PubMed Web of Science ®Google Scholar
• Kumar R. K., Penny R. Cell-mediated immune deficiency in Hodgkin's disease. Immunol. Today 1982; 3: 269–273
   PubMedGoogle Scholar
• Uccini S., Monardo F., Stoppacciaro A., Gradilone A., Agliano A. M., Faggioni A., Vittorio M., Luca V., Costanzi G., Ruco L. P., Baroni C. D. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease in HIV-positive patients. Int. J. Cancer 1990; 46: 581–585
   PubMed Web of Science ®Google Scholar
• Gattringer G., Greil R., Radaszkiewicz T., Huber H. In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: Quantity and quality of infiltration density depends on histopathological subtype. Blut 1986; 53: 49–58
   PubMedGoogle Scholar
• Sanchez-Madrid F., Krensky A. M., Ware C. F., Robbins E., Strominger J. L., Burakoff S. J., Springer T. A. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2 and LFA-3. Proc. Natl. Acad. Sci. USA 1982; 79: 7489–7493
   PubMed Web of Science ®Google Scholar
• Johnson J. P., Shaw S. Cluster report: CD54. In:. Leucocyte Typing IV. While Cell Differentiation Antigens, W. Knapp, B. Dörken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. K. R. von dem Borne. Oxford University Press, Oxford: 1989; 681–683
   Google Scholar
• Rowe M., Evans H. S., Young L. S., Hennessy K., Kieff E., Rickinson A. B. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 1987; 68: 1575–1586
   PubMed Web of Science ®Google Scholar